Prognostic utility of metabolic exercise testing in minimally symptomatic patients with obstructive hypertrophic cardiomyopathy

Paul Sorajja, Thomas Allison, Courtney Hayes, Rick A. Nishimura, Carolyn S P Lam, Steve R. Ommen

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Patients with obstructive hypertrophic cardiomyopathy (HC) are at increased risk of death or severe symptoms. Although metabolic exercise testing is routinely used in the evaluation of a variety of cardiac diseases, data on the prognostic information that can be derived from such testing in HC is lacking. We examined 182 patients (mean age 53 ± 15 years; 65% men) with obstructive HC and minimal or no cardiovascular symptoms. Each patient underwent maximum exercise testing with simultaneous metabolic gas exchange measurement. Follow-up (mean 4.0 ± 3.0 years; 100% complete) was performed to determine the vital status and occurrence of severe symptoms, defined as class III or IV symptoms of dyspnea or angina. Multiple parameters of metabolic exercise were associated with a risk of death and the development of severe symptoms. On multivariate analyses, the independent predictors of death and severe symptoms were the severity of the left ventricular outflow tract gradient at rest and the percentage of predicted peak myocardial oxygen consumption achieved during exercise. For patients with a percentage of predicted peak myocardial oxygen consumption of <60%, the 4-year survival rate free of death and severe symptoms was only 59%. In conclusion, among patients with obstructive HC and mild or no symptoms, a low metabolic exercise capacity is associated with an increased risk of death and the subsequent development of severe symptoms.

Original languageEnglish (US)
Pages (from-to)1494-1498
Number of pages5
JournalAmerican Journal of Cardiology
Volume109
Issue number10
DOIs
StatePublished - May 15 2012

Fingerprint

Hypertrophic Cardiomyopathy
Exercise
Oxygen Consumption
Dyspnea
Heart Diseases
Multivariate Analysis
Survival Rate
Gases

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Prognostic utility of metabolic exercise testing in minimally symptomatic patients with obstructive hypertrophic cardiomyopathy. / Sorajja, Paul; Allison, Thomas; Hayes, Courtney; Nishimura, Rick A.; Lam, Carolyn S P; Ommen, Steve R.

In: American Journal of Cardiology, Vol. 109, No. 10, 15.05.2012, p. 1494-1498.

Research output: Contribution to journalArticle

Sorajja, Paul ; Allison, Thomas ; Hayes, Courtney ; Nishimura, Rick A. ; Lam, Carolyn S P ; Ommen, Steve R. / Prognostic utility of metabolic exercise testing in minimally symptomatic patients with obstructive hypertrophic cardiomyopathy. In: American Journal of Cardiology. 2012 ; Vol. 109, No. 10. pp. 1494-1498.
@article{f12c2ca817154b82a35366e5c10f9ea3,
title = "Prognostic utility of metabolic exercise testing in minimally symptomatic patients with obstructive hypertrophic cardiomyopathy",
abstract = "Patients with obstructive hypertrophic cardiomyopathy (HC) are at increased risk of death or severe symptoms. Although metabolic exercise testing is routinely used in the evaluation of a variety of cardiac diseases, data on the prognostic information that can be derived from such testing in HC is lacking. We examined 182 patients (mean age 53 ± 15 years; 65{\%} men) with obstructive HC and minimal or no cardiovascular symptoms. Each patient underwent maximum exercise testing with simultaneous metabolic gas exchange measurement. Follow-up (mean 4.0 ± 3.0 years; 100{\%} complete) was performed to determine the vital status and occurrence of severe symptoms, defined as class III or IV symptoms of dyspnea or angina. Multiple parameters of metabolic exercise were associated with a risk of death and the development of severe symptoms. On multivariate analyses, the independent predictors of death and severe symptoms were the severity of the left ventricular outflow tract gradient at rest and the percentage of predicted peak myocardial oxygen consumption achieved during exercise. For patients with a percentage of predicted peak myocardial oxygen consumption of <60{\%}, the 4-year survival rate free of death and severe symptoms was only 59{\%}. In conclusion, among patients with obstructive HC and mild or no symptoms, a low metabolic exercise capacity is associated with an increased risk of death and the subsequent development of severe symptoms.",
author = "Paul Sorajja and Thomas Allison and Courtney Hayes and Nishimura, {Rick A.} and Lam, {Carolyn S P} and Ommen, {Steve R.}",
year = "2012",
month = "5",
day = "15",
doi = "10.1016/j.amjcard.2012.01.363",
language = "English (US)",
volume = "109",
pages = "1494--1498",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Prognostic utility of metabolic exercise testing in minimally symptomatic patients with obstructive hypertrophic cardiomyopathy

AU - Sorajja, Paul

AU - Allison, Thomas

AU - Hayes, Courtney

AU - Nishimura, Rick A.

AU - Lam, Carolyn S P

AU - Ommen, Steve R.

PY - 2012/5/15

Y1 - 2012/5/15

N2 - Patients with obstructive hypertrophic cardiomyopathy (HC) are at increased risk of death or severe symptoms. Although metabolic exercise testing is routinely used in the evaluation of a variety of cardiac diseases, data on the prognostic information that can be derived from such testing in HC is lacking. We examined 182 patients (mean age 53 ± 15 years; 65% men) with obstructive HC and minimal or no cardiovascular symptoms. Each patient underwent maximum exercise testing with simultaneous metabolic gas exchange measurement. Follow-up (mean 4.0 ± 3.0 years; 100% complete) was performed to determine the vital status and occurrence of severe symptoms, defined as class III or IV symptoms of dyspnea or angina. Multiple parameters of metabolic exercise were associated with a risk of death and the development of severe symptoms. On multivariate analyses, the independent predictors of death and severe symptoms were the severity of the left ventricular outflow tract gradient at rest and the percentage of predicted peak myocardial oxygen consumption achieved during exercise. For patients with a percentage of predicted peak myocardial oxygen consumption of <60%, the 4-year survival rate free of death and severe symptoms was only 59%. In conclusion, among patients with obstructive HC and mild or no symptoms, a low metabolic exercise capacity is associated with an increased risk of death and the subsequent development of severe symptoms.

AB - Patients with obstructive hypertrophic cardiomyopathy (HC) are at increased risk of death or severe symptoms. Although metabolic exercise testing is routinely used in the evaluation of a variety of cardiac diseases, data on the prognostic information that can be derived from such testing in HC is lacking. We examined 182 patients (mean age 53 ± 15 years; 65% men) with obstructive HC and minimal or no cardiovascular symptoms. Each patient underwent maximum exercise testing with simultaneous metabolic gas exchange measurement. Follow-up (mean 4.0 ± 3.0 years; 100% complete) was performed to determine the vital status and occurrence of severe symptoms, defined as class III or IV symptoms of dyspnea or angina. Multiple parameters of metabolic exercise were associated with a risk of death and the development of severe symptoms. On multivariate analyses, the independent predictors of death and severe symptoms were the severity of the left ventricular outflow tract gradient at rest and the percentage of predicted peak myocardial oxygen consumption achieved during exercise. For patients with a percentage of predicted peak myocardial oxygen consumption of <60%, the 4-year survival rate free of death and severe symptoms was only 59%. In conclusion, among patients with obstructive HC and mild or no symptoms, a low metabolic exercise capacity is associated with an increased risk of death and the subsequent development of severe symptoms.

UR - http://www.scopus.com/inward/record.url?scp=84860452705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860452705&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2012.01.363

DO - 10.1016/j.amjcard.2012.01.363

M3 - Article

C2 - 22356797

AN - SCOPUS:84860452705

VL - 109

SP - 1494

EP - 1498

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 10

ER -